Full Name
Alexandre Chan
Variants
Chan, A.
Chan, Alexandre
Chan A
 
 
 
Email
gmschal@nus.edu.sg
 

Publications

Results 61-80 of 96 (Search time: 0.012 seconds).

Issue DateTitleAuthor(s)
61Dec-2011Impact of erythropoiesis-stimulating agent prescribing at an Asian cancer center, after release of safety advisoriesChan, Q.; Chan, A. 
622016Impact of TNF-α (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer PatientsChae J.-W.; Ng T.; Yeo H.L.; Shwe M.; Gan Y.X.; HO HAN KIAT ; Chan A. 
63Oct-2009Improving pharmaceutical care in oncology by pharmacoinformatics: the evolving role of informatics and the internet for drug therapyYap, K.Y.-L.; Chan, A. ; Chui, W.K. 
64Jul-2012Incidence of febrile neutropenia among early-stage breast cancer patients receiving anthracycline-based chemotherapyChan, A. ; Chen, C.; Chiang, J.; Tan, S.H.; Ng, R.
65Jul-2009Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphomaLai, G.G.Y.; Lim, S.-T.; Tao, M.; Chan, A. ; Li, H.; Quek, R.
66Mar-2013Linguistic validation of Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog): Methodological concernsCheung, Y.T.; Chan, A. 
672007Liposomal doxorubicin-associated acute hypersensitivity despite appropriate preventive measuresChan, A. ; Shih, V.; Kian, T.C.
68Dec-2011Management of tumor lysis syndrome with a single fixed dose of rasburicase in Asian lymphoma patients: A case series and literature reviewChiang, J.; Chan, A. ; Lian, T.; Tay, K.; Quek, R.; Tao, M.; Lim, S.T.
6931-May-2014Management options for established chemotherapy-induced peripheral neuropathyPachman, D.R.; Watson, J.C.; Lustberg, M.B.; Wagner-Johnston, N.D.; Chan, A. ; Broadfield, L.; Cheung, Y.T.; Steer, C.; Storey, D.J.; Chandwani, K.D.; Paice, J.; Jean-Pierre, P.; Oh, J.; Kamath, J.; Fallon, M.; Strik, H.; Koeppen, S.; Loprinzi, C.L.
702015Metabolism-related pharmacokinetic drug-drug interactions with tyrosine kinase inhibitors: Current understanding, challenges and recommendationsTeo Y.L ; Ho H.K ; Chan A 
712014Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: Cognitive function (FACT-Cog) in breast cancer patientsCheung, Y.T.; Foo, Y.L.; Shwe, M.; Tan, Y.P.; Fan, G.; Yong, W.S.; Madhukumar, P.; Ooi, W.S.; Chay, W.Y.; Dent, R.A. ; Ang, S.F.; Lo, S.K.; Yap, Y.S.; Ng, R. ; Chan, A. 
72Jul-2012Neuro-cognitive impairment in breast cancer patients: Pharmacological considerationsCheung, Y.T.; Chui, W.K. ; Chan, A. 
732009Oncoinformatics for the healthcare professional: Oncology databases and blogsYap, K.Y.-L.; Chen, Y.Z. ; Chui, W.K. ; Chan, A. 
7418-Feb-2010OncoRx-IQ: A tool for quality assessment of online anticancer drug interactionsYi-Lwern Yap, K.; Raaj, S.; Chan, A. 
7511-Jun-2019Optimizing Vancomycin Dosing in Chronic Kidney Disease by Deriving and Implementing a Web-Based Tool Using a Population Pharmacokinetics AnalysisDorajoo, Sreemanee Raaj; Winata, Chrystal Leandra; Goh, Jessica Hui Fen; Ooi, Say Tat; Somani, Jyoti; Yeoh, Lee Ying; Lee, Siok Ying; Yap, Chun Wei; Chan, Alexandre ; Chae, Jung-woo
762009Patients' perspectives and safe handling of oral anticancer drugs at an Asian cancer centerChan, A. ; Leow, Y.C.; Sim, M.H.
77Dec-2011Polypharmacy in elderly patients with cancer: Clinical implications and managementLees, J.; Chan, A. 
78Oct-2013Potentially inappropriate prescribing and drug-drug interactions among elderly Chinese nursing home residents in MacaoLao, C.K.; Ho, S.C.; Chan, K.K.; Tou, C.F.; Tong, H.H.Y.; Chan, A. 
79Aug-2012Prevalence of the Coprescription of Clinically Important Interacting Drug Combinations Involving Oral Anticancer Agents in Singapore: A Retrospective Database StudyKo, Y. ; Tan, S.L.D.; Chan, A. ; Wong, Y.-P.; Yong, W.-P. ; Ng, R.C.H.; Lim, S.-W. ; Salim, A. 
801-Jun-2011Preventing oxaliplatin-induced sensory neurotoxicity: A methodology perspectiveChan, A. ; Chiang, J.; Lew, K.Y.; Chay, W.Y.